FDA NDC Directory · JSON-LD · Markdown

Fludeoxyglucose F 18

NDC 75913-647 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerWashington University School of Medicine
Marketing categoryAbbreviated NDA (generic) · App ANDA203935
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsFLUDEOXYGLUCOSE F-18 (300 mCi/mL)
Marketing started20110102
Package count1

External sources

Source: openFDA. Public-domain (CC0).